Thursday, May 8, 2025
spot_img

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025

PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
[email protected]   

Media Contact:
Laurene Isip
(609) 208-8121
[email protected] 

Integra LifeSciences Holdings Corporation

Powered by SlickText.com

Hot this week

Form 8.3 – Warehouse REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – Urban Logistics REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – Primary Health Properties Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – LondonMetric Property Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Topics

Form 8.3 – Warehouse REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – Urban Logistics REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – Primary Health Properties Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – LondonMetric Property Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – Life Science REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

No. 12/2025 – CeMat A/S acquires right of perpetual usufruct to land plot in Bielany, Warsaw

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K   ...

Form 8.3 – GlobalData Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...
spot_img

Related Articles

Popular Categories

spot_img